Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2008 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: AMIODARONE HYDROCHLORIDE

« Back to Dashboard

Summary for Tradename: AMIODARONE HYDROCHLORIDE

Patents:0
Applicants:22
NDAs:25

Clinical Trials for: AMIODARONE HYDROCHLORIDE

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Status: Terminated Condition: Defibrillators, Implantable; Tachycardia, Ventricular

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
Status: Active, not recruiting Condition: Atrial Fibrillation

Amiodarone for the Prevention of Reperfusion Ventricular Fibrillation
Status: Completed Condition: Other Intraoperative Cardiac Functional Disturbances During Cardiac Surgery

Concentrations of Amiodarone in Fat Tissue During Chronic Treatment
Status: Completed Condition: Arrhythmia; Atrial Fibrillation; Atrial Flutter

Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation
Status: Completed Condition: Persistent Atrial Fibrillation

Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF
Status: Not yet recruiting Condition: Atrial Fibrillation

Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
Status: Not yet recruiting Condition: Chagas Cardiomyopathy; Non-sustained Ventricular Tachycardia; At Least 10 Points in Rassi Risk Score for Death

Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation
Status: Completed Condition: Atrial Fibrillation

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
Status: Completed Condition: Atrial Fibrillation

Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft
Status: Completed Condition: Atrial Fibrillation

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Hospira
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE; INJECTION075955Oct 18, 2002RXYes<disabled><disabled>
Bioniche Pharma
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE; INJECTION076217Oct 15, 2002RXYes<disabled><disabled>
Teva Pharms
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET; ORAL074739Nov 30, 1998RXNo<disabled><disabled>
Gland Pharma Ltd
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE; INJECTION077161Apr 20, 2005RXYes<disabled><disabled>
Zydus Pharms Usa Inc
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
TABLET; ORAL079029Sep 16, 2008RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc